Actively Recruiting
Observational Study on Safety and Performance of Tipmed Primary Hip Prosthesis System in Adults Undergoing Hip Replacement Surgery
Led by TIPMED Medical Device Manufacturing Ltd. Co. · Updated on 2026-06-16
101
Participants Needed
4
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are observing adult patients who have undergone primary hip arthroplasty using the Tipmed Primary Hip Prosthesis System. This study aims to collect real-world data on the devices safety, possible complications, and joint function up to 24 months after surgery during routine clinical use. It includes patients who have had total or partial hip replacement across multiple centers in Turkey. Participants receive the Tipmed Primary Hip Prosthesis System as part of their standard orthopedic care. The device includes options such as cemented or uncemented stems, acetabular cups, bipolar cups, and titanium shells tailored to patient anatomy. The study follows patients for 24 months after surgery with assessments at six scheduled visits 6 weeks, 3 months, 6 months, 12 months, 18 months, and 24 months post-operation. During each follow-up, clinical data and joint function are recorded using the Harris Hip Score. Investigators track adverse events, serious adverse events, and implant-related complications like dislocation or infection. Radiological and laboratory results are documented when available. The study analyzes safety and effectiveness outcomes with statistical methods, including subgroup analysis for partial hip replacements, ensuring thorough evaluation over two years.
CONDITIONS
Brief Title
Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Primary Hip Prosthesis System
Research Team
Y
Yasemin Önel, Sponsor Rep
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here